Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|July 1, 2002
Supplements and Featured Publications
- Symposium Reporter: Reaching Goal - Conquering the Treatment Gaps in Dyslipidemia
- Volume 8
- Issue 2 Symp
Statin Pharmacology May Have Important Clinical Implications
Author(s)James M. McKenney, PharmD
Advertisement
Articles in this issue
about 24 years ago
Role of hs-CRP in Cardiovascular Risk Predictionabout 24 years ago
Changes in ATP III focus on diabetes and the metabolic syndromeabout 24 years ago
Role of managed care in implementing NCEP-ATP III guidelinesabout 24 years ago
Aggressive Lipid Reduction Provides Additional Clinical BenefitAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Student Mental Health, Success Tied to Future Health and Affordability
5